Regents of the University of Minnesota

Date of Award

07.23.2020

Program

Prevent & Delay

Amount

$950,000.00

Term of Grant

39 months

Project Title

Phase 2: Engineering antigen-specific regulatory T cells for use in type 1 diabetes

Project Description

Funds will support studies to develop an engineered targeted Treg cell therapy to treat type 1 diabetes.